The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

Life Biosciences tests ER-100, a gene therapy that aims to restore vision by rejuvenating damaged retinal neurons.

Imagine a city where your morning commute flows seamlessly, public services respond to your needs in real time, and ...

Vuzix Corporation (NASDAQ: VUZI) is expanding its presence in defense technology through an extended collaboration with Collins Aerospace, a subsidiary of RTX (NYSE: RTX). The partnership focuses on ...

Rob and Brenda Rettig, partners in New Vision Farms based out of Napoleon, Ohio, step us through the process of testing popcorn. The couple manages all of the post-harvest testing and data collection ...

Surgeons at Rambam Eye Institute have made medical history. They restored sight to a legally blind patient using a fully 3D printed corneal implant grown entirely from cultured human corneal cells.

The newest store in Lake Zurich won't open until Friday morning, but that hasn't stopped would-be patrons from knocking on the door in hopes of getting a sneak peek. “There's a lot of buzz going ...

Patricia DeLucia has spent decades studying something many of us never think about: judgments about collision that are crucial for safety. But the roots of her research stretch back to her childhood, ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. At the heart of this initiative is a simple but powerful idea: artificial ...

Zurich Insurance Group has announced the launch of the Zurich AI Lab, a new initiative focused on artificial intelligence research and development. The project is led by Group CEO Mario Greco ...